Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer (Q35006809)

5 August 2017

title

Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer (English)

1 reference

5 August 2017

1 reference

L. Huiart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21522148

30 November 2024

S. Dell'Aniello

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21522148

30 November 2024

S. Suissa

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21522148

30 November 2024

language of work or name

English

0 references

publication date

26 April 2011

1 reference

full work available at URL

5 August 2017

https://www.nature.com/articles/bjc2011140.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21522148

https://europepmc.org/articles/PMC3101914

30 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21522148

https://europepmc.org/articles/PMC3101914?pdf=render

30 November 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21522148

http://www.nature.com/articles/bjc2011140.pdf

30 November 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.2011.140

http://www.nature.com/articles/bjc2011140

30 November 2024

1 reference

https://api.crossref.org/works/10.1038/BJC.2011.140

British Journal of Cancer

30 November 2024

published in

1 reference

5 August 2017

volume

104

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

1558-1563

1 reference

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Patient adherence and persistence with oral anticancer treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Medication compliance and persistence: terminology and definitions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Adherence to tamoxifen over the five-year course

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Methods for evaluation of medication adherence and persistence using automated databases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

8 July 2018

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

How rapidly do oncologists respond to clinical trial data?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Adherence to therapy with oral antineoplastic agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Tamoxifen for early breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Validation of the diagnosis of venous thromboembolism in general practice database studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Clinical information for research; the use of general practice databases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

The relation between survival and age at diagnosis in breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Early discontinuation of tamoxifen: a lesson for oncologists.

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Clinical trial presentations, agency guidelines, and oncology practice: findings from the arimidex, tamoxifen, alone or in combination trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Validity of the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Age differences in the psychosocial problems encountered by breast cancer patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101914

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial

26 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

21 January 2018

1 reference

12 December 2020

Prospects for antiestrogen chemoprevention of breast cancer

1 reference

12 December 2020

Younger women with breast carcinoma have a poorer prognosis than older women

1 reference

12 December 2020

Validation of pharmacy records in drug exposure assessment

1 reference

12 December 2020

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 reference

12 December 2020

Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness

1 reference

12 December 2020

Meta-analyses, multivariate analyses, and coping with the play of chance

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

7 January 2021

inferred from DOI database lookup

Cochrane Database of Systematic Reviews

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.140

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/BJC.2011.140

1 reference

release_dc35j65xrfbwliepv3zuhgokii

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dc35j65xrfbwliepv3zuhgokii

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3101914

1 reference

5 August 2017

1 reference